Conference Paper/Proceeding/Abstract 363 views
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
M Moe,
M Almatari,
P Ali,
P Willshaw,
Peter Willshaw
Journal of Clinical Oncology, Volume: 27, Issue: 15, Start page: supplement S
Swansea University Author: Peter Willshaw
Full text not available from this repository: check for access using links below.
Abstract
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines
Published in: | Journal of Clinical Oncology |
---|---|
ISSN: | 0732-183X |
Published: |
2009
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa10808 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2013-07-23T12:04:19Z |
---|---|
last_indexed |
2018-02-09T04:39:57Z |
id |
cronfa10808 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>10808</id><entry>2012-05-29</entry><title>Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines</title><swanseaauthors><author><sid>4cb70423fbd01750747f24fd7cc2e410</sid><firstname>Peter</firstname><surname>Willshaw</surname><name>Peter Willshaw</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2012-05-29</date><deptcode>HIS</deptcode><abstract/><type>Conference Paper/Proceeding/Abstract</type><journal>Journal of Clinical Oncology</journal><volume>27</volume><journalNumber>15</journalNumber><paginationStart>supplement S</paginationStart><paginationEnd/><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0732-183X</issnPrint><issnElectronic/><keywords/><publishedDay>20</publishedDay><publishedMonth>5</publishedMonth><publishedYear>2009</publishedYear><publishedDate>2009-05-20</publishedDate><doi/><url/><notes/><college>COLLEGE NANME</college><department>Interprofessional Studies</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HIS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-06-26T16:42:59.2529641</lastEdited><Created>2012-05-29T15:04:51.1205247</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>M</firstname><surname>Moe</surname><order>1</order></author><author><firstname>M</firstname><surname>Almatari</surname><order>2</order></author><author><firstname>P</firstname><surname>Ali</surname><order>3</order></author><author><firstname>P</firstname><surname>Willshaw</surname><order>4</order></author><author><firstname>Peter</firstname><surname>Willshaw</surname><order>5</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
v2 10808 2012-05-29 Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines 4cb70423fbd01750747f24fd7cc2e410 Peter Willshaw Peter Willshaw true false 2012-05-29 HIS Conference Paper/Proceeding/Abstract Journal of Clinical Oncology 27 15 supplement S 0732-183X 20 5 2009 2009-05-20 COLLEGE NANME Interprofessional Studies COLLEGE CODE HIS Swansea University 2023-06-26T16:42:59.2529641 2012-05-29T15:04:51.1205247 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine M Moe 1 M Almatari 2 P Ali 3 P Willshaw 4 Peter Willshaw 5 |
title |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines |
spellingShingle |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines Peter Willshaw |
title_short |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines |
title_full |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines |
title_fullStr |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines |
title_full_unstemmed |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines |
title_sort |
Bisphosphonate therapy requirement during adjuvant aromatase inhibitor therapy in early breast cancer patients according to UK bone health guidelines |
author_id_str_mv |
4cb70423fbd01750747f24fd7cc2e410 |
author_id_fullname_str_mv |
4cb70423fbd01750747f24fd7cc2e410_***_Peter Willshaw |
author |
Peter Willshaw |
author2 |
M Moe M Almatari P Ali P Willshaw Peter Willshaw |
format |
Conference Paper/Proceeding/Abstract |
container_title |
Journal of Clinical Oncology |
container_volume |
27 |
container_issue |
15 |
container_start_page |
supplement S |
publishDate |
2009 |
institution |
Swansea University |
issn |
0732-183X |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
published_date |
2009-05-20T16:42:54Z |
_version_ |
1769780464185245696 |
score |
11.02167 |